Alaunos Therapeutics, Inc. (TCRT)
1.50
-0.06
(-3.85%)
USD |
NASDAQ |
Sep 10, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Alaunos Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.0842 |
| June 30, 2023 | 0.0722 |
| March 31, 2023 | 0.4609 |
| December 31, 2022 | 0.5061 |
| September 30, 2022 | 0.7954 |
| June 30, 2022 | 0.685 |
| March 31, 2022 | 0.598 |
| December 31, 2021 | 0.5058 |
| September 30, 2021 | 0.4312 |
| June 30, 2021 | 0.0641 |
| March 31, 2021 | 0.0438 |
| December 31, 2020 | 0.0388 |
| September 30, 2020 | 0.0174 |
| June 30, 2020 | 0.0122 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0121 |
| December 31, 2019 | 0.0248 |
| September 30, 2019 | 0.0125 |
| June 30, 2019 | 0.0232 |
| March 31, 2019 | 0.0215 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -2.290 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.516M |
| Total Liabilities (Quarterly) | 0.864M |
| Shareholders Equity (Quarterly) | 0.652M |
| Current Ratio | 0.7708 |